Company Overview of Raze Therapeutics, Inc.
Raze Therapeutics, Inc., a biotechnology company, engages in the discovery and development of oncology therapeutics. It offers a pipeline of one-carbon (1C) metabolism therapeutics across a range of solid and hematologic cancers, including genetically-defined cancers, as well as supports tumor biomass accumulation. The company was founded in 2013 and is based in Cambridge, Massachusetts.
25 First Street
Cambridge, MA 02141
Founded in 2013
Key Executives for Raze Therapeutics, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3Bar Biologics Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|The Advertising Council, Inc.||United States|
|NYC2012, Inc.||United States|
|Tax Management Inc||United States|
Sponsored Financial Commentaries
To contact Raze Therapeutics, Inc., please visit www.razetx.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.